IV Diazepam Dosing for Acute Anxiety Management

Safety Considerations

Increased risk of apnea when diazepam is given rapidly IV or when combined with other sedative agents, and respiratory assistance facilities should be readily available during administration, with monitoring of oxygen saturation and respiratory effort throughout treatment, and preparation to support ventilation if necessary, as recommended by the American Academy of Pediatrics 1
For elderly or debilitated patients, consider reduced dosing, starting at the lower end of the dosage range, according to the British Medical Association guidelines 2

Sedation and respiratory depression, especially when combined with other sedative agents, can occur, as reported by the American Academy of Pediatrics 1
Paradoxical excitement or agitation, especially in younger patients, is a potential adverse effect, as noted by the American Academy of Pediatrics 3

Flumazenil may be administered to reverse life-threatening respiratory depression caused by diazepam, but it also counteracts the anxiolytic effects and may precipitate seizures in patients with seizure disorders, as recommended by the American Academy of Pediatrics 1

Consider non-pharmacological approaches as adjuncts to medication management, as suggested by the British Medical Association guidelines 2